Furthermore, our study provides the first evidence of the role of lactadherin in metastatic BC cell-secreted sEVs: (i) as a promoter of metastatic capacity in less aggressive recipient cells in vitro, and ii) its effects on the formation of ascites and metastatic tumor nodules in vivo. This evidence concerns the gene MFGE8 and breast cancer.